Thane Wettig; Interim Chief Executive Officer, Chief Commercial Officer; FibroGen Inc. David Delucia; Vice Presi ...

mild to moderate anemia, and neutropenia. Challenges to PARPi therapy include the development of resistance via drug efflux mechanisms, PARP1 mutations, replication fork protection—where certain ...

Slow the rate of infusion for mild (Grade 1) and interrupt the infusion ... (7%), fatigue (6%), pneumonia (6%), anemia (4.3%), neutropenia (4.3%), white blood cell count decreased (4.3%), rash ...

Hematologic Toxicity: Treatment with imatinib can cause anemia, neutropenia ... Patients with mild hepatic impairment (total bilirubin ≤ upper limit of normal [ULN] and aspartate ...

Rouleau formation was mild in all cases ... blood was not seen even in the patients with thrombocytopenia. Although neutropenia has been noted in inorganic arsenic intoxication 8,9,11–13,15 ...

HAIC monotherapy demonstrated relatively mild toxicity, primarily affecting hepatobiliary ... HAIC combined with targeted, and immunotherapy exhibited the highest adverse reaction rates (neutropenia ...

He wasn’t even allowed Calpol, which did have a mild beneficial effect on him. This caused a severe crash resulting in him refusing food, a bed, any bedding for 10 days. He lived on the floor of ...

In March 2022, after 59 cycles of ibrutinib, the patient experienced his first relapse, characterized by the recurrence of lymphocytosis and mild thrombocytopenia ... The triplet regimen was well ...

Adverse events other than diarrhoea, abdominal cramps, possible sperm reduction and mild abnormalities of liver enzymes–all discussed elsewhere in this document—are extremely rare but include alopecia ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...